期刊文献+

脑出血大鼠脑内轴突生长抑制因子受体的表达及NEP1-40干预的实验研究

Experimental Study of the Expression of Axonal Growth Inhibitory Factor Receptor in Brain of Rats with Cerebral Hemorrhage and NEPI-40 Intervention
下载PDF
导出
摘要 【目的】通过实验观察脑出血大鼠脑内轴突生长抑制因子受体(NgR)的变化规律及给予干预措施后的变化。【方法】检测脑出血大鼠脑内NGR的表达规律,同时给脑出血大鼠模型腹腔注射有干扰受体表达的干扰剂NEP1—40,考察NEP1~40对血NGR的表达抑制效果。【结果】模型成功后,脑出血大鼠出血侧的皮质及海马NGR—mRNA表达强度增加,在24h和2d时最高,且与模型组比较差异有显著性(P〈0.01),当给予NEPl—40后,出血侧NgR—mRNA表达强度与模型组比呈现不同程度的降低,其中以24h和2d时间点的检测结果有差异(P〈O.05)。【结论】NEP1—40对脑出血大鼠出血侧NgR的表达有一定阻断能力,可为脑出血后神经功能恢复的治疗方法研究提供一个参考。 [Objective] To observe the variation of brain axonal growth inhibitory factor receptor(NGR) in rat with cerebral hemorrhage by experiment, and its change after intervention. [Methods]The variation of the expression of brain NGR in rats with cerebral hemorrhage was detected. Meanwhile, rat models with cerebral hemorrhage were intraperitoneally injected with intervention agent NEP1-40 interfering the receptor expres sion. The inhibitory efficacy of NEP1-40 for the expression of blood NGR was observed. [Results] After the successful establishment of the model, the expression of NGR mRNA in cortex and hippocampus at hemor- rhagic side of rats with cerebral hemorrhage increased and was up to the highest at 24h and 2d, and there was significant difference in comparison with model group ( P d0.01). After NEP1-40 intervention, the expres- sion of NGR mRNA decreased with different degree at hemorrhagic side in comparison with the model group, and there was significant difference in the expression level between at 24h and 2d( P〈0.05). [Conclusion] NEP1-40 can block the expression of NGR at hemorrhagic side of rats with cerebral hemorrhage so as to pro vide a reference for the recovery of neurological function after cerebral hemorrhage.
出处 《医学临床研究》 CAS 2013年第1期32-34,共3页 Journal of Clinical Research
基金 广东省湛江市第一批非资助科技攻关计划项目(序号:36,项目编号:2012C3101036)
关键词 脑出A 病理学 受体 大鼠 cerebral hemorrhage/PA antibodies rats
  • 相关文献

参考文献9

  • 1Del Bigio MR,Yah HJ,Buist R. Experimental intracerebral hemorrhmge in rats:magnetic resonance imaging and histopathological correlates[J].Stroke,1996,(12):2312-2320.
  • 2程发峰,宋文婷,郭少英,钟相根,鲁艺,王庆国.三种神经功能评分在鼠类局灶性脑缺血模型评价中的比较[J].中国康复医学杂志,2011,26(4):337-341. 被引量:42
  • 3McGee AW,Strittmatter SM. The Nogo-66 receptor:focusing myelin inhibition of axon regeneration[J].Trends in Neurosciences,2003,(04):193-198.
  • 4GrandPré T,Li S,Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration[J].Nature,2002,(6888):547-551.
  • 5Li S,Strittmatter SM. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury[J].The Journal of Neuroscience,2003,(10):4219-4227.
  • 6Kim JE,Liu BP,Park JH. Nogo-66 receptor prevents raphespinaland rubrospinal axon regeneration and limits functional recovery fromspinal cord injury[J].Neuron,2004,(03):439-451.
  • 7Fischer D,He Z,Benowitz LI. Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state[J].The Journal of Neuroscience,2004,(07):1646-1651.
  • 8Ma J,Tian WM,Hou SP. An experimental test of stroke recovery by implanting a hyaluronic acid hydrogel carrying a Nogo receptor antibody in a rat model[J].Biomedical Materials,2007,(04):233-240.
  • 9Yu P,Huang L,Zou J. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats[J].Neurobiology of Disease,2008,(03):535-542.

二级参考文献15

  • 1张占军,王忠,李澎涛,张文生,李喜悦,黄启福,王永炎.清开灵组分配伍干预局灶性脑缺血大鼠再灌注损伤的实验研究[J].中国药理学通报,2006,22(8):964-967. 被引量:22
  • 2贾子善,李阔,槐雅萍,高俊淑,李娜.不同环境干预对局灶性脑梗死大鼠行为学恢复的影响[J].中国康复医学杂志,2007,22(7):578-580. 被引量:31
  • 3Willing AE. Experimental models: help or hindrance[J]. Stroke, 2009,40(3 Suppl):S152-154.
  • 4Fisher M, Feuerstein G, Howells DW, et al. Update of the stroke therapy academic industry, roundtable preclinical recommendations[J]. Stroke,2009,40(6):2244-2250.
  • 5Rother J. Neuroprotection does not work[J].Stroke,2008,39(2): 523-524.
  • 6Gareia JH, Wagner S, Liu KF, et al. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation[J]. Stroke,1995,26(4): 627-634.
  • 7Clark WM, Lessor NS, Dixon MP, et al. Monofilament intraluminal middle cerebral artery occlusion in the mouse[J]. Neurol res, 1997,19(6):641-648.
  • 8Hua Q, Zhu X, Li P, et al. Refined Qing Kai Ling, traditional Chinese medicinal preparation, reduces ischemic stroke-induced infarct size and neurological deficits and increases expression of endothelial nitric oxide synthase[J]. Biol pharm bull, 2008,31(4):633-637.
  • 9Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination[J]. Stroke,1986,17(3):472-476.
  • 10Recoramendations for standards regarding preclinical neuroprotective and restorative drug development[J]. Stroke,1999,30(12): 2752-2758.

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部